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Splicing Regulation at the Second Catalytic Step
by Sex-lethal Involves
3 Splice Site Recognition by SPF45
substantial rearrangements within the spliceosome
(Schwer and Guthrie, 1992; Ansari and Schwer, 1995;
Sawa and Shimura, 1991; Chua and Reed, 1999a,
1999b). Work in Saccharomyces cerevisiae, for example,
identified a DEXH helicase—Prp16p—that associates
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with the 3 ss region after lariat formation and inducesEuropean Molecular Biology Laboratory
ATP-driven conformational rearrangements that resultMeyerhofstraße 1
in replacement of Prp16p by Slu7p and Prp18p, whichD-69117 Heidelberg
are protein factors important for 3 ss activation (SchwerGermany
and Guthrie, 1991, 1992; Frank and Guthrie, 1992; Ansari3 School of Life Sciences
and Schwer, 1995; Jones et al., 1995; Umen and Guthrie,University of Dundee
1995b). At least six conserved proteins and two snRNAsMSI/WTB Complex, Dow Street
are known to interact with the pre-mRNA in the vicinityDundee DD1 5EH
of the 3 ss and/or influence 3 ss choice (reviewed inScotland
Umen and Guthrie, 1995a; Moore, 2000). In addition,United Kingdom
human proteins have been identified that associate with
spliceosomes after the first catalytic step (Gozani et al.,
1994). These proteins play a role in the second step ofSummary
splicing (Gozani et al., 1994; Tronche´re et al., 1997; Ajuh
et al., 2000) or crosslink to the AG dinucleotide at theThe Drosophila protein Sex-lethal (SXL) promotes
time of the second catalytic step (Wu and Green, 1997).skipping of exon 3 from its own pre-mRNA. An unusual
However, the identity of factors that recognize and acti-sequence arrangement of two AG dinucleotides and
vate the AG dinucleotide during the second catalytican intervening polypyrimidine (Py)-tract at the 3 end
step remains unresolved.of intron 2 is important for Sxl autoregulation. Here
The protein SPF45 was previously identified as a com-we show that U2AF interacts with the Py-tract and
ponent of splicing complexes, with a subnuclear local-downstream AG, whereas the spliceosomal protein
ization characteristic of splicing factors (Neubauer etSPF45 interacts with the upstream AG and activates
al., 1998). Its biochemical properties and function in theit for the second catalytic step of the splicing reaction.
splicing process, however, had not been investigated.SPF45 represents a new class of second step factors,
Here we show that SPF45 directly binds to a 3 ss AGand its interaction with SXL blocks splicing at the sec-
and promotes its utilization during the second catalyticond step. These results are in contrast with other
step.known mechanisms of splicing regulation, which tar-
Pre-mRNA splicing is often regulated during cell dif-get early events of spliceosome assembly. A similar
ferentiation and development to generate mRNAs thatrole for SPF45 is demonstrated in the activation of a
encode distinct proteins from a single primary transcriptcryptic 3 ss generated by a mutation that causes hu-
(Graveley, 2001). Regulation is usually accomplished byman -thalassemia.
promoting or repressing early events in spliceosome
assembly (Smith and Valca´rcel, 2000). The Drosophila
Introduction protein Sex-lethal (SXL) is specifically expressed in fe-
male flies and controls alternative splicing of genes in-
Removal of introns from mRNA precursors is carried volved in sexual differentiation, behavior, and X chromo-
out by a complex of small nuclear ribonucleoprotein some dosage compensation (Schu¨tt and No¨thiger,
particles (snRNPS) and non-snRNP polypeptides (i.e., 2000). SXL also controls its own expression. In the ab-
the spliceosome) and takes place in two steps (Will and sence of SXL (in male flies), exon 3 is incorporated into
Lu¨hrmann, 2001; Hastings and Krainer, 2001). First, Sxl mRNAs. These mRNAs cannot encode a functional
cleavage occurs between the upstream exon and the protein because exon 3 contains termination codons in-
intron. Second, exons are ligated and the intron is re- frame with the initiator ATG located in exon 2. Expres-
leased in a lariat configuration. sion of SXL protein in female flies causes skipping of
The 3 end of introns is recognized in higher eukary- exon 3 and results in the production of an mRNA encod-
otes by the U2 auxiliary factor (U2AF), which is com- ing full-length SXL (Figure 1A; Bell et al., 1991).
posed of two subunits of 65 and 35 kDa. U2AF65 binds For some of the genes regulated by SXL, e.g., trans-
to the pyrimidine-rich (Py) tract that precedes the 3 former (tra) and male-specific-lethal 2 (msl-2), uridine-
splice site (ss) AG, which is recognized by U2AF35 (Za- rich sequences that serve as SXL binding sites are lo-
more et al., 1992; Wu et al., 1999; Zorio and Blumenthal, cated at the regulated splice sites (Sosnowski et al.,
1999; Merendino et al., 1999). 1989; Inoue et al., 1990; Kelley et al., 1995). Biochemical
Activation of the 3 ss to undergo catalysis requires data are compatible with a model in which SXL blocks
the access of splicing factors to these sites (Valca´rcel
et al., 1993; Merendino et al., 1999; Fo¨rch et al., 2001).4 Correspondence: juan.valcarcel@embl-heidelberg.de
Sxl autoregulation, however, is unlikely to be explained5 Present address: Theraupetic Targets S.L., Saturno 1, Tres Cantos,
28760 Madrid, Spain. by simple splice site occlusion because most SXL bind-
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Figure 1. In Vitro Splicing of Sxl-Derived Pre-mRNAs
(A) Schematic representation of Sxl genomic region subject to sex-specific alternative splicing. Exon 3 is included in the absence of SXL
(male flies) and skipped in its presence (females). Exons are represented by boxes, introns by thin lines, and patterns of alternative splicing
by thick lines. Exon 3 inclusion involves splicing to the proximal AG upstream from the Py-tract (Penalva et al., 2001; see text). Ovals represent
potential SXL binding sites. The positions of SXL initiator codon in exon 2 and one of several in-frame stop codons in exon 3 are indicated.
The nucleotide sequence of the 3 ss regions of RNAs analyzed in this study is also shown. AGs are underlined (P represents proximal and
D distal 3 ss). Mutations are indicated in bold case. bp indicates the nucleotide used as branch point, mapped by primer extension as
described (Ruskin et al., 1986).
(B) In vitro splicing of A3S and mutant derivatives. The indicated radioactively labeled RNAs were incubated with nuclear extracts in the
presence or absence of ATP as indicated. RNAs were then purified and fractionated by electrophoresis on denaturing 13% polyacrylamide
gels. The positions of pre-mRNAs and products are schematically represented to the right. Boxes indicate exons; thin lines indicate introns.
The positions of intermediates and products corresponding to the use of the proximal (P) and distal 3 ss (D) is indicated.
(C) Spliceosome assembly analysis of the reactions shown in (B). The indicated radioactively labeled RNAs were fractionated on agarose-
polyacrylamide gels that can resolve hnRNP complexes (H) from prespliceosomal (A) and spliceosomal (B and C) AdML complexes.
ing sites required for regulation are remote from the exon ligation. Mutation of the proximal 3 ss induces
the use of the distal 3 ss and, intriguingly, also compro-regulated splice sites (Sakamoto et al., 1992; Horabin
and Schedl, 1993; Wang and Bell, 1994). An amino- mises the ability of SXL to induce exon 3 skipping (Pe-
nalva et al., 2001). We set out to investigate the molecu-terminal glycine-rich region of SXL has been implicated
in cooperative RNA binding and shown to be important lar basis for these observations.
No splicing of transcripts spanning Sxl exons 2–4 withfor autoregulation (Wang and Bell, 1994).
Here we report that, in contrast to regulatory mecha- either Drosophila or human nuclear extracts under a
variety of experimental conditions was detected. Thisnisms described so far, SXL inhibits the last step of the
splicing process. SXL accomplishes this by interacting was also the case for deleted transcripts lacking seg-
ments of introns 2 and/or 3 (data not shown). Therefore,through its amino-terminal domain with SPF45.
a chimeric RNA (A3S) was generated where the 3 end
of an Adenovirus (AdML) intron was substituted by theResults
corresponding region of Sxl intron 2 (including both
proximal and distal 3 ss). Incubation of A3S RNA underSex-lethal (SXL) protein promotes skipping of exon 3
from its own pre-mRNA (Figure 1A). This exon is unusual splicing conditions resulted in the ATP-dependent accu-
mulation of splicing intermediates and products (Figurein that it is preceded by two alternative 3 ss AGs (Bell
et al., 1991; Penalva et al., 2001). The nucleotide se- 1B, compare lanes 3 and 4). The major spliced product
corresponds in size to utilization of the proximal 3 splicequence of Sxl intron 2/exon 3 boundary is shown in
Figure 1A. The 3 ss AG distal (D) to the 5 ss and its site, as confirmed by its isolation and sequencing (data
not shown). This is reminiscent of the preferential useassociated polypyrimidine (Py)-tract are important for
exon 3 definition, because their mutation results in exon of the proximal 3 ss in male Drosophila flies and in
Schneider cells transfected with a Sxl minigene (Penalva3 skipping even in the absence of SXL protein. The
proximal (P) 3 ss, however, is preferentially used for et al., 2001). Three other features of this 3 ss region
SPF45 and Sxl Autoregulation
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observed in vivo were also recapitulated in vitro using suggesting that recognition of the distal 3 ss—
presumably by U2AF35 (Figure 2B)—is important for rec-the A3S substrate. First, the distal site was utilized upon
mutation of the proximal 3 ss AG (compare lanes 4 and ognition of the proximal 3 ss by the 45 kDa species.
Two lines of evidence indicated that the 45 kDa spe-6; the use of the distal site was confirmed by sequencing
of the product). Second, mutation of either the distal AG cies was the spliceosomal protein SPF45. First, the 45
kDa species crosslinked to the proximal AG was effi-or its associated Py-tract resulted in general inhibition of
splicing (lanes 8 and 10). Third, consistent with the idea ciently and specifically immunoprecipitated by antibod-
ies that recognize either a peptide region of SPF45 orthat the distal 3 ss region is important for early events
involved in spliceosome assembly, both mutation of the the complete protein (Figure 2D, left, compare lanes 1
and 7 with lanes 4 and 10, and data not shown). AsPy-tract and mutation of the distal 3 ss AG resulted
in reduction of prespliceosomal complex A formation observed for the 45 kDa crosslinking product, mutation
of either the proximal or the distal 3 ss reduced SPF45(Figure 1C, compare lanes 4 with 8 and 10). We conclude
that in vitro splicing of the A3S RNA in HeLa nuclear crosslinking (Figure 2D, left, compare lane 1 with lanes 2
and 3). Second, purified recombinant His-tagged SPF45extracts recapitulates characteristic properties of this
unusual arrangement of 3 ss as observed for Sxl exon added to nuclear extracts crosslinked to the RNA specif-
ically labeled at the proximal AG, but not to a mutant3 in vivo.
derivative in which the AG was mutated to CA, and was
precipitated by nickel-agarose beads (Figure 2D, right,Proteins that Interact with P and D 3 ss
lanes 1 and 2). No signal was detected when recombi-To identify factors associated with the proximal and
nant SPF45 was not added to the extract (lane 3).distal splice sites, ultraviolet (UV) light-mediated cross-
We conclude that the 45 kDa species is SPF45 andlinking assays were carried out. To test whether U2AF65
that it specifically recognizes the proximal 3 ss AGwas associated with the Py-tract of A3S RNA, the tran-
in the A3S RNA. This interaction is dependent uponscript was uniformly labeled with [32P]uridine, incubated
recognition of the Py-tract and distal 3 ss, most likelywith nuclear extract under splicing conditions, and irra-
by U2AF65 and U2AF35. Consistent with this, SPF45diated with UV light, and after treatment with RNase A,
crosslinking was compromised in nuclear extracts de-immunoprecipitation was carried out using anti-U2AF65
pleted of the U2AF heterodimer (data not shown).antibodies. U2AF65 was crosslinked to the wild-type RNA
but not to a mutant RNA in which a stretch of eight
uridines at the Py-tract was substituted by cytidines SPF45 Is Important for SXL Autoregulation
Previous results have shown that mutation of the proxi-(Figure 2A, compare lanes 1 and 4). This suggests that
U2AF65 interacts with the Py-tract immediately upstream mal AG compromises the ability of SXL to induce skip-
ping of exon 3 from its own pre-mRNA (Penalva et al.,from the distal 3 ss. Mutation of the distal 3 ss AG
reduced U2AF65 crosslinking (lane 3), while mutation of 2001), suggesting that recognition of the proximal site
facilitates Sxl autoregulation. If this recognition involvesthe proximal AG did not (lane 2). This suggests that the
distal 3 ss belongs to the category of AG-dependent SPF45, interference with SPF45 activity should compro-
mise SXL function. To test this prediction, we used dou-3 ss, which are reliant upon interaction between U2AF35
and the downstream 3 ss AG to stabilize U2AF65 binding ble-stranded RNA (dsRNA) to interfere with endogenous
SPF45 function in Drosophila cells. Schneider cells wereto a Py-tract (Reed, 1989; Wu et al., 1999). Consistent
with this hypothesis, a 35 kDa species was crosslinked transfected with dsRNA corresponding to a Drosophila
SPF45 cDNA obtained from an embryo library, or trans-to a A3S transcript in which a single radioactive phos-
phate was incorporated between the A and G at the fected with various control dsRNAs. The levels of SPF45
mRNA were reduced at least 20-fold (data not shown).distal 3 ss (data not shown), and this crosslinked spe-
cies could be immunoprecipitated using antibodies A reporter minigene containing Sxl exons 2–4 was co-
transfected with increasing concentrations of a SXL-against U2AF35 (Figure 2B, lane 1). The crosslinking was
specific because U2AF35 was not crosslinked when the encoding plasmid or with empty vector. While cotrans-
fection with limited amounts of SXL-encoding plasmidAG was mutated to CA and the label was introduced
between C and A (compare lanes 1 and 2). Taken to- induced complete skipping of exon 3 in cells that had
been treated with control dsRNA (Figure 3A, lanes 1–4),gether, the results shown in Figures 2A and 2B indicate
that U2AF65 interacts with the Py-tract at the distal 3 SXL-induced exon skipping was reduced in cells treated
with SPF45 dsRNA (lanes 5–8). For example, while trans-ss and that U2AF35 interacts with the distal 3 ss AG.
To identify factors recognizing the proximal 3 ss AG, fection with 0.004 g/ml of SXL-encoding plasmid re-
sulted in quantitative skipping of exon 3 in cells cotrans-a A3S RNA was prepared in which a single radioactive
phosphate was incorporated between the A and G at fected with control dsRNA (lane 2), transfection with
20-fold higher concentrations of SXL-encoding plasmidthe proximal 3 ss AG. Upon incubation with nuclear
extract under splicing conditions, UV light irradiation, resulted in less than 50% exon skipping in the presence
of SPF45 dsRNA (lane 8). The effect could be specificallyand RNase A digestion, a crosslinked product of around
45 kDa was detected (Figure 2C, lane 1). Several results attributed to SPF45 expression because efficient regula-
tion by SXL was restored by overexpression of humansuggested that this species was relevant to the switch
in 3 ss utilization associated with exon 3 splicing and SPF45 in these cells (lanes 9–12). The nucleotide se-
quence of human and Drosophila SPF45 is sufficientlyits regulation. First, crosslinking was specific because
it was abolished by mutation of the proximal AG to CA different so that Drosophila SPF45 dsRNA does not in-
terfere with human SPF45 expression. The effects ob-(A3S-mutP, lane 2). Second, crosslinking was reduced
by mutation of the distal 3 ss AG (A3S-mutD, lane 3), served were not due to changes in the expression of
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Figure 2. Identification of Factors that Bind to the 3 ss of Sxl Exon 3
(A) The indicated RNAs were uniformly labeled with [32P]uridine, incubated with nuclear extracts in the absence of ATP, and after incubation
at 30C for 15 min, irradiated with 265 nm ultraviolet (UV) light and digested with RNase A, and the products of crosslinking were immunoprecipi-
tated with anti-U2AF65 monoclonal antibodies or a control (ctrl) antibody. The sizes of molecular weight markers are indicated to the left.
(B) Crosslinking/immunoprecipitation as in (A) with RNAs site-specifically labeled at either the distal 3 ss of A3S or at an equivalent position
in a mutant substrate (A3S-mutD), using antibodies against U2AF35 or a preimmune serum (ctrl). The nucleotide sequence and position labeled
in A3S and A3S-mutD RNAs is indicated. Asterisks indicate the position of the radioactive phosphate.
(C) Pattern of polypeptides crosslinked to RNAs site-specifically labeled at the proximal 3 ss. Asterisks indicate the position of the radioactive
phosphate. After UV irradiation and digestion with RNase A, crosslinked products were directly resolved on SDS-polyacrylamide gels.
(D) SPF45 crosslinking to proximal 3 ss AG. Left: products of immunoprecipitation of crosslinking reactions set up as in (C) using anti-SPF45
antibodies or preimmune serum, fractionated on denaturing SDS polyacrylamide gels. Right: precipitation with nickel agarose beads of
crosslinking products corresponding to reactions set up as in (C) either in the presence or the absence of exogenously added recombinant
purified His-SPF45.
SXL, because neither dsRNA-mediated interference nor of the proximal 3 ss AG (Figure 3; Penalva et al., 2001),
we propose that both interaction with and activation ofoverexpression of SPF45 changed the levels of SXL
protein (Figure 3B). We conclude that interference with the proximal 3 ss by SPF45 are important for efficient
Sxl autoregulation.SPF45 expression compromises the ability of SXL to
promote exon 3 skipping.
To test whether interference with SPF45 function influ- SPF45 Is a Second Step Factor
To analyze the function of SPF45, HeLa nuclear extractsenced the relative use of the proximal and distal sites,
RT-PCR assays were carried out using primers designed were immunodepleted of this factor and their splicing
activity was analyzed. Immunodepletion reduced theto distinguish between products generated by the use
of each of the splice sites (Penalva et al., 2001). While levels of SPF45 to less than 10% of mock-depleted
extracts (Figure 4A). Splicing assays showed that deple-the proximal site is preferentially used in control cells
(as previously reported, Penalva et al., 2001), the distal tion with preimmune serum resulted in a relative in-
crease in the use of the distal site and accumulationsite is preferentially used in cells transfected with SPF45
dsRNA (Figure 3C, compare lanes 1 and 2). Overexpres- of the corresponding lariat product (compare lane 2 in
Figure 4B with lane 4 in Figure 1B). These effects may,sion of hSPF45 increased the use of the proximal site
(lane 3), arguing that the effects on 3 ss utilization were however, be related to nonspecific (e.g., dilution) effects
of the depletion procedure, because splicing assaysspecifically related to SPF45 activity. These observa-
tions suggest that SPF45 activity correlates with the use carried out with nuclear extract preparations differing
in overall protein concentration also resulted in differentof the proximal site.
Based on the interaction data presented in the previ- degrees of distal site utilization (data not shown). SPF45
depletion resulted in reduced levels of spliced mRNAsous section and the observation that interference with
SPF45 function has effects similar to those of mutation and lariat products, and a concomitant increase in the
SPF45 and Sxl Autoregulation
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Figure 3. RNA Interference of SPF45 Compromises Sxl Autorregulation
(A) RT-PCR analyses of RNA isolated from Schneider cells transiently transfected with the pRmHA-234 Sxl genomic reporter and increasing
concentrations (indicated in g per 60 mm tissue culture plate) of the SXL expression plasmid pRmHA-SXL in the presence of dsRNA
corresponding to dSPF45 or control dsRNA. The sizes of the products of amplification corresponding to exon 3 inclusion (2-3-4) or skipping
(2-4) are indicated at the right. Cotransfection with an expression vector for human SPF45 is indicated by . RNAs were isolated 72 hr
posttransfection.
(B) Expression of HA-tagged SXL in the experiment shown in (A). Extracts from transfected cells were fractionated on SDS polyacrylamide
gels, and HA-tagged SXL expression was analyzed by Western blot using anti-HA antibodies.
(C) Relative use of Sxl exon 3 3 ss in Schneider cells transiently transfected with a Sxl reporter and dsRNA corresponding to dSPF45 or a
control gene, with or without cotransfection with an expression vector for human SPF45. RT-PCR was performed using primers corresponding
to exons 2 and 3 that should generate products of amplification differing by 18 bp, depending on whether the proximal or the distal 3 splice
site is used. Minigene TE234 were cotransfected in SL2 cells with 15 g of dsRNA control or dsRNA of dSPF45 in the absence or presence
of an expression vector for human SPF45.
levels of intermediates generated by the first step of requires binding sites for the protein within the pre-
mRNA. However, addition of SXL to splicing reactionssplicing (Figure 4B). These effects could be partially
reversed by addition of recombinant purified hSPF45 to containing A3SU RNA caused inhibition of the second
step of splicing and accumulation of the first exon andthe depleted extracts (compare lanes 3 and 4). SPF45
depletion affected utilization of the proximal but not the lariat intermediate (Figure 5B, compare lanes 2 and 3).
Importantly, SXL had no effect on splicing of the A3SU-distal 3 ss. Moreover, SPF45 depletion had little or no
effect on splicing of the mutant A3S-mutP RNA, in which mutP RNA, which contains SXL binding sites but lacks
the proximal 3 ss (Figure 5B, compare lanes 6 and 7).the proximal site was mutated from AG to CA (A3S-
mutP) (Figure 4C). Together, these findings suggest that This suggests that the A3SU RNA was made refractory
to SXL inhibition by preventing recognition of the proxi-the proximal and distal 3 ss show different requirements
for SPF45. mal 3 ss by SPF45.
We conclude that SXL inhibits A3SU splicing at a late
step in the splicing process and that inhibition requires
SXL Inhibits A3S Splicing at the Second activation of the proximal 3 ss by SPF45.
Catalytic Step
To investigate the possibility that SXL regulates selec-
tion of the 3 ss at a step related to SPF45 activity, a Mechanism of Regulation
To test whether SXL inhibited the association of SPF45derivative of A3S RNA was generated in which a well-
characterized SXL binding site (Handa et al., 1999) was with the proximal 3 ss, crosslinking and immunoprecipi-
tation experiments were carried out essentially as inintroduced both upstream and downstream of the 3 ss
region (Figure 5A, A3SU). This RNA maintained both the Figure 2D. The results indicate that inhibition of A3SU
splicing by SXL was not related to a block of SPF45preferential use of the proximal 3 ss (Figure 5B, lane
2), as well as the activation of the distal 3 ss upon interaction with the pre-mRNA (Figure 5C, compare
lanes 1 and 2). Next we considered the possibility thatmutation of the proximal site (Figure 5B, lane 6). SXL
had no effect on A3S splicing (data not shown), consis- SXL and SPF45 interact directly with each other. In vitro
translated SPF45 was coprecipitated with recombinanttent with the expectation that splicing regulation by SXL
Cell
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Figure 4. SPF45 Modulates the Second Catalytic Step
(A) Extent of SPF45 depletion from HeLa nuclear extracts. Western blot analyses of the levels of SPF45 in serial dilutions of nuclear extracts
(NE), SPF45 immunodepleted extracts (SPF45), or mock-depleted extracts (MOCK). MW indicates position of molecular weight markers.
(B) Effects of SPF45 immunodepletion on splicing of A3S pre-mRNA. A3S RNA was incubated in mock-depleted extracts (MOCK) or SPF45
immunodepleted extracts (SPF45) in the absence or presence of ATP and in the absence or presence of recombinant purified His-hSPF45
(100 ng/l) as indicated. RNAs were then purified and fractionated on 13% polyacrylamide gels. Positions of splicing intermediates and
products are indicated on the right.
(C) Effects of SPF45 immunodepletion on splicing of A3S-mutP pre-mRNA. Splicing assays were carried out as in (B) using A3S-mutP as
substrate.
purified GST-SXL using glutathione-agarose beads (Fig- directly interacting with its amino-terminal region and
thereby blocking its activity as a second step splicingure 5D, lane 5). To map the domains involved in the
interaction (schematically represented at the top of Fig- factor.
ure 5D), GST pull-down experiments were carried out
using (1) GST-SXL and derivatives containing either only SPF45 and Activation of the 110
Thalassemic Mutationits amino-terminal glycine-asparagine-rich 94 amino
acids (GST-GN) or lacking this region of the protein The arrangement of 3 ss in Sxl exon 3 is reminiscent
of that created in-globin pre-mRNAs by the-thalasse-[GST-SXL(GN)] and (2) in vitro translated SPF45 or mu-
tants deleting the 196 amino-terminal amino acids, the mic mutation 110. 110 is a guanine to adenine substitu-
tion that generates a cryptic 3 ss AG upstream from thecentral DIII domain (including a G-Patch motif), or the
carboxy-terminal RRM. Only GST-SXL and GST-GN co- normal 3 ss of-globin intron 1 (Figure 6A). Activation of
the cryptic site results in a change in reading frame andprecipitated SPF45 as well as its amino-terminal domain
(lanes 5 and 6 and 13 and 14), indicating that SXL and therefore in an mRNA that cannot code for globin, thus
giving rise to the-thalassemic condition. Previous workSPF45 interact through their amino termini.
Previous work has shown that the amino-terminal do- indicated that activation of the cryptic site was depen-
dent upon the integrity of the natural 3 ss (Krainer etmain of SXL is important for Sxl autoregulation in vivo
(Wang and Bell, 1994). Guided by these in vivo results al., 1985; Zhuang and Weiner, 1990), similar to the de-
pendence on the distal site for proximal site activationand by the interaction between SXL and SPF45 de-
scribed above, the activity of a SXL derivative lacking in Sxl exon 3. Given the similarities between the two
systems, we hypothesized that SPF45 could be involvedthe 94 amino-terminal amino acids was tested in in vitro
splicing assays. This mutant was unable to inhibit the in activation of the 110 cryptic 3 ss. To test this possibil-
ity, we made use of the cell culture system describedsecond step of A3SU RNA splicing (Figure 5B, lane 4),
thus recapitulating one additional property of Sxl auto- in Figure 3, where SPF45 activity could be efficiently
depleted and this effect reversed by overexpression ofregulation as observed in vivo. Crosslinking and precipi-
tation of GST-SXL and GST-SXL(GN) from the same human SPF45. Minigenes containing -globin intron 1,
with or without mutation 110, were transfected intoreaction mixtures suggested that the two proteins
bound similarly to the A3SU RNA (Figure 5E, compare Schneider cells that had been cotransfected with either
SPF45 dsRNA or control dsRNA. The relative use of thelanes 2–4 with lanes 5–7). These results establish a cor-
relation between the ability of SXL to interact with SPF45 normal and cryptic 3 ss was determined by RT-PCR
using primers designed to allow discrimination betweenand its ability to inhibit the second catalytic step. Taken
together, the data are consistent with a model in which the use of each of the sites. The natural 3 ss was used in
cells transfected with the wild-type minigene and controlSXL inhibits splicing of SPF45-dependent substrates by
SPF45 and Sxl Autoregulation
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Figure 5. SXL Inhibits the Second Step of A3SU Splicing
(A) Nucleotide sequence of the 3 end of A3SU and A3SU-mutP transcripts.
(B) In vitro splicing of AS3U and AS3U-mutP. Splicing assays were carried out in the absence or presence of ATP and recombinant purified
GST-SXL (100 ng/l) or GST-SXL(GN) (200 ng/l) as indicated. RNAs were fractionated on 13% polyacrylamide gels. Positions of splicing
intermediates and products are indicated. The RNA species labeled with an asterisk most likely corresponds to the debranched linear form
of the intron.
(C) Crosslinking of SPF45 to A3SU and A3SU-mutP RNAs. Reactions set up as in (B) were irradiated with UV light, and immunoprecipitation
assays were carried out as in Figure 2D.
(D) Interaction between SXL and SPF45. Top: Schematic representation of the domain organization of SXL and dSPF45. a, b, and c correspond
to the amino-terminal, DIII/Glycine patch and RRM domains of SPF45, respectively. Bottom left: Products of in vitro translation of 35S-labeled
full-length (FL) or deletion mutants of dSPF45, fractionated on SDS-polyacrylamide gels. Bottom right: Coprecipitation of in vitro translated
dSPF45 and deletion mutants with various GST fusion proteins using glutathione-agarose beads. GST-GN contains SXL amino acids 1–94,
while GST-SXL(GN) lacks these residues compared to full-length GST-SXL.
(E) Crosslinking of GST-SXL and GST-SXL(GN) to A3SU RNA. Reactions set up as in (B) with the indicated amounts of GST-SXL and GST-
SXL(GN) were irradiated with UV light, and the GST fusions were precipitated using glutathione-agarose beads. The precipitates were
fractionated on SDS-polyacrylamide gels and autoradiographed.
dsRNA (Figure 6B, lane 1), while the cryptic 3 ss was mal site is important for regulation of exon skipping by
the SXL protein. In this study we have investigated theused in cells transfected with the minigene containing
the 110 mutation (lane 2). These results indicate that molecular mechanisms behind these observations using
a combination of in vitro assays and RNA interferencesplice site selection for the -globin constructs in
Schneider cells recapitulated that reported for the en- in Drosophila Schneider cells. We provide evidence that
the two subunits of U2AF bind to the Py-tract and distaldogenous gene in human cells. Consistent with an
involvement of SPF45 in cryptic splice site activation, AG to facilitate spliceosome assembly, and we identify
the spliceosomal protein SPF45 as a second step splic-cotransfection with dSPF45 dsRNA resulted in partial
activation of the normal 3 ss (lane 3). This effect could ing factor important for both recognition and utilization
of the proximal 3 ss of Sxl exon 3. The activation func-be reversed by overexpression of hSPF45 (lane 4).
Taken together, the results suggest a common molec- tion of SPF45 during the second catalytic step can be
inhibited by binding to SXL, thereby providing an unan-ular basis for the switch in 3 ss utilization observed in
Sxl exon 3 and for the activation of a cryptic 3 ss in ticipated mechanism for regulation of splice site utili-
zation.-globin by the110 mutation. In both cases, SPF45 plays
a role in the utilization of an upstream 3 ss AG.
SPF45 Is a Second Step Splicing Factor
The amino acid sequence and domain organization ofDiscussion
SPF45 is different from other second step factors identi-
fied so far. SPF45 contains a carboxy-terminal RNA rec-Previous work indicated that while the Py-tract and dis-
tal AG are important for Sxl exon 3 definition, a proximal ognition motif (RRM) that is most closely related to that
found in U2AF35 (Birney et al., 1993). As both U2AF35 andAG is utilized as 3 ss during catalysis. Use of the proxi-
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Figure 6. SPF45 Is Involved in Activation of
a Cryptic 3 ss in the  Thalassemic Mutation
110
(A) Nucleotide sequence of the 3 ss region
of the first intron in human -globin and in
the -thalassemic mutation 110. Cryptic and
natural 3 ss are indicated.
(B) Analysis of 3 ss AG utilization. RT-PCR
analysis using primers corresponding to
-globin exons 1 and 2 predicted to generate
amplification products that differ by 18 nucle-
otides depending on whether the natural or
cryptic 3 ss AG were utilized. The positions
of the corresponding products are indicated.
RNAs used in the RT-PCR reactions were pu-
rified from Schneider cells transfected with a
wild-type -globin minigene or the 110 mu-
tant, in the presence of dsRNA corresponding
to SPF45 or a control dsRNA, as indicated.
Cotransfection with an expression vector for
human SPF45 () or empty vector () is also
indicated. Abbreviations: MOCK, RNA from
untransfected cells; MW, positions of the mo-
lecular weight markers.
SPF45 contact 3 ss AGs, it is conceivable that their either absence of SPF45 or mutation of the proximal
site results in use of the distal site (Figures 7B and 7C).rather unusual RRMs are domains specialized in 3 ss
AG recognition. In this context it is noteworthy that a Several models have been proposed for how the 3
ss AG is specified after the first catalytic step, includingU2AF35-related protein, URP, was found to play a role
in the second catalytic step in human nuclear extracts (1) scanning of the first AG from the branchpoint (Smith
et al., 1989, 1993; Chen et al., 2000), (2) optimal distance(Tronche´re et al., 1997). The existence of multiple factors
recognizing the 3 ss AG may be required to increase to the branchpoint, and (3) a combination of distance
constraints and competition between 3 ss of differentthe accuracy of exon ligation. Consistent with this idea,
depletion of the human second step factor SLU7p re- strengths (Brys and Schwer, 1996; Luukkonen and Se´r-
aphin, 1997; Chiara et al., 1997; Chua and Reed, 2001).sults in catalytic activation of incorrect AGs (Chua and
Reed, 1999b). Similarly, SPF45 binds to and directs cata- SPF45 could be an important component of these scan-
ning/measuring mechanisms.lytic activation of the proximal 3 ss AG (Figure 7A), while
Figure 7. Model for SPF45 Function and
Regulation by SXL
(A) Schematic representation of Sxl pre-
mRNA in which intron 2 has undergone the
first catalytic step of splicing, leading to accu-
mulation of free exon 2 and intron 2 in lariat
configuration. The position of the proximal
(p) and distal (d) 3 ss AG, Py-tract (Py), and
binding sites for the U2AF subunits and
SPF45 at the 3 end of intron 2 are indicated.
The arrow represents the second catalytic
step of splicing occurring between exon 2
and the proximal AG, an event promoted by
SPF45.
(B) Mutation of the proximal AG prevents in-
teraction with SPF45 and leads to exon 3 in-
clusion utilizing the distal AG.
(C) Depletion of SPF45 prevents utilization of
the proximal AG, which—as in (B)—leads to
exon 3 inclusion utilizing the distal AG.
(D) Interaction between the glycine-rich (G) domain of SXL and SPF45 interferes with the activity of SPF45 that promotes utilization of the
proximal AG during the second catalytic step (crossed arrow). The distal site is not activated in the presence of SXL, suggesting that SPF45
bound to SXL is still capable of selecting the proximal over the distal site, but fails to activate it for catalysis. As a result, exon 2 is spliced
to exon 4, and exon 3 is skipped from the mature mRNA. The intron preceding exon 4 may have undergone the first catalytic step and be in
lariat configuration at the time of exon 2-exon 4 ligation (not represented). SXL binding is represented for simplicity as a single binding site
in the Figure, but multiple uridine-rich sequences within introns 2 and 3 contribute to Sxl autoregulation (Sakamoto et al., 1992).
(E) Mutation of the proximal site prevents interaction with SPF45 and disrupts SXL-mediated exon skipping, because SXL cannot prevent
splicing between exon 2 and the distal 3 ss AG.
(F) Depletion of SPF45 results in utilization of the distal 3 ss for exon 3 inclusion. As in (E), SXL cannot inhibit splicing between exon 2 and
the distal 3 ss AG, and therefore the protein fails to promote exon 3 skipping.
SPF45 and Sxl Autoregulation
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Interaction of SPF45 with the proximal 3 ss required which SXL acts at early stages of spliceosome assembly
(Granadino et al., 1997, and data not shown). We con-recognition of the distal Py-tract/3 ss by U2AF65/35. As
SPF45 was detected in immunoprecipitates of U2AF clude that SXL can regulate splicing of different genes
by distinct mechanisms that have different domain re-washed under mild conditions (P. Fo¨rch, A. Bachi, M.
Wilms, and J.V., unpublished observations), SPF45 may quirements and that target either early or late steps in
the splicing process.be delivered to the proximal 3 ss region through associ-
ation with complexes containing U2AF. Traditional models of splicing regulation target early
stages of splice site recognition (Smith and Valca´rcel,Here we show that different 3 ss have different re-
quirements for SPF45. For example, biochemical deple- 2000). What could be the rationale for the selection of
a mechanism of regulation that targets the second cata-tion of SPF45 compromised splicing of the A3S sub-
strate but not of the A3S-mutP RNA (Figures 4B and lytic step? Male flies have a strong requirement for effi-
cient inclusion of exon 3. Even low levels of exon skip-4C). Similarly, in vivo depletion of SPF45 levels by RNA
interference reduced utilization of the proximal site in ping in the absence of SXL could result in accumulation
of SXL-encoding mRNAs that could switch on the auto-Sxl or of the cryptic 3 ss in -globin, while it did not
compromise the use of the distal site in Sxl, nor the use regulation process and establish SXL expression. In
other words, the process of exon definition must be veryof the 3 ss in the downstream intron 3, nor the use of
the wild-type 3 ss in -globin (Figures 3C and 6). We efficient to keep a tight control over sex identity and
viability. This may impose, however, serious mechanis-cannot completely rule out, however, that more exten-
sive in vivo or in vitro depletion than achievable using tic problems to regulators attempting to interfere with
early steps of spliceosome assembly. Inhibition of thethe currently available reagents would not reveal a more
general requirement for SPF45 in splicing. second catalytic step may allow SXL to effectively pro-
mote skipping of exon 3 after it has been recognized
as an exon but before it is included in the spliced prod-SPF45 and Sxl Autoregulation
uct. Dual recognition of the 3 ss and dependence onFigure 7 presents a model for Sxl autoregulation and
SPF45 may provide a particularly favorable opportunitythe involvement of SPF45 in this process. As mentioned
for regulation at a late step of the splicing process.above, SPF45 interaction with the proximal AG facili-
Consistent with a role for SPF45 in Sxl autoregulationtates proximal site utilization during the second catalytic
in vivo, initial experiments indicate that microinjectionstep (Figure 7A). Interaction of SPF45 requires early rec-
of SPF45 dsRNA, but not of control dsRNA, compro-ognition of the Py-tract and distal AG by the two subunits
mises the viability of female embryos (data not shown),of U2AF. Either mutation of the proximal AG (Figure 7B)
which is the characteristic phenotype of Sxl loss of func-or depletion of SPF45 (Figure 7C) led to utilization of
tion mutations (reviewed by Cline and Meyer, 1996).the distal site, without compromising exon 3 inclusion.
We are aware of two other pre-mRNAs where a down-In the presence of SXL, however, exon 3 is skipped
stream AG (which under certain circumstances can(Figure 7D), and two lines of evidence indicate that this
function as a 3 ss) is required for catalytic activationeffect of SXL requires the interaction between SPF45
of an upstream 3 ss AG. One occurs in the polyomaand the proximal AG. First, mutation of the proximal AG
virus early transcriptional unit, which gives rise to middleprevents SPF45 interaction, and in this situation exon 3
T or small t antigens depending on which AG of the pairis included using the distal site, even in the presence
is used (Ge et al., 1990). It is likely that mechanismsof SXL (Figure 7E). This suggests that SXL bound to the
exist to modulate the extent of activation of each 3 sspre-mRNA cannot prevent splicing of exon 2 to the distal
during viral infection. The other example is the activation3 ss AG (Figure 7E). Similarly, depletion of SPF45 also
of a cryptic site in -globin by the -thalassemic muta-prevents proximal site utilization, and again splicing of
tion 110 (Krainer et al., 1985; Zhuang and Weiner, 1990).exon 2 to the distal site is not inhibited by SXL (Figure
We showed here that interference with SPF45 function7F). Taken together, the data suggest that SXL causes
in Schneider cells resulted in partial inhibition of crypticexon 3 skipping by inhibiting the function of SPF45 as
site activation and concomitant accumulation of cor-a second step splicing factor that promotes utilization
rectly spliced transcripts. These results raise the interest-of the proximal site for exon ligation (Figure 7D).
ing possibility that SPF45 could be used as a therapeuticSXL does not prevent SPF45 from binding to the proxi-
target for treating at least one class of -thalassemias.mal 3 ss. Instead, the two proteins interact through
Finally, these results strongly suggest that the mecha-their N termini. In this way, SXL inhibits SPF45 function
nism of cryptic splice site activation is likely to be similar(Figure 7D). As the distal site is not activated in the
to that observed for the activation of the proximal 3 sspresence of SXL, SPF45 bound to SXL is still capable
in Sxl exon 3, implying a more general role for SPF45of selecting the proximal over the distal site, but fails
in splicing control.to activate it for catalysis. These observations, therefore,
suggest three distinct functions for SPF45: specific rec-
ognition of the proximal 3 ss, commitment of this site Experimental Procedures
to splicing, and finally catalytic activation during the
Expression of SPF45 and Antibody Productionsecond step. The amino-terminal domain of SXL is im-
Human SPF45 cDNA (Neubauer et al., 1998) was amplified from aportant for Sxl autoregulation in vivo (Wang and Bell,
human bone marrow library (Clontech) and cloned in the Drosophila1994) and is essential for SXL to repress the second
cupper-inducible expression vector pRmHa and in the prokaryotic
catalytic step (Figure 5B). The domain is, however, dis- expression vector pET (Novagen). Human His-SPF45 was expressed
pensable for RNA binding in our assays (Figure 5E) and in BL21 E. coli by inducing cultures (at OD 0.6) of cells transformed
with the pRSET-SPF45 plasmid with 1 mM IPTG for 3 hr at 30Cfor regulating splicing in vitro of other substrates in
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and purification under nondenaturing conditions by affinity chroma- Transfection and RNA Interference
Transfection of Schneider cells, RNA isolation, and RT-PCR analy-tography on nickel beads (Talon, Clontech).
Homology searches in FlyBase identified the Drosophila melano- ses were as described previously (Penalva et al., 2001). RNA inter-
ference was achieved using 6 g/ml of double-stranded RNAgaster gene AE002927 as the putative homolog of SPF45. dSPF45
cDNA was obtained by cloning a product of PCR amplification from generated by in vitro transcription using T7 RNA polymerase and
PCR-generated templates containing T7 promoters at both ends ofan embryo stage V cDNA library (Clontech) using oligonucleotides
corresponding to the 5 and 3 ends of SPF45 ORF. the sequences corresponding to GFP (entire ORF, 717 bp) or SPF45
(ORF nucleotides 1–605). The products of transcription were heatedAntibodies were raised (EUROGENTECH, Belgium) in rabbits
against a peptide with the sequence NH2-CPYEEDSRPRSQSSKA- at 65C for 30 min and kept at room temperature for 1 hr before
addition to the cultures at the time of Lipofectin-mediated trans-COOH coupled to keyhole limpet hemacyanine or in sheep against
the full-length protein (Scottish Antibody Production Unit). fection.
3 ss Usage AnalysesSplicing Substrates and Reporters
We analyzed 15 g of total RNA from cells transfected with pRmHa-A3S was generated by replacing the sequence CAUACUUAUCCU
234 or pRmHA-/110 globin plasmids by RT-PCR using the followingGUCCCUUUUUUUUCCACAG from the intron 1 of adenovirus major
primer pairs: GGTTGCTTTGCGTTACAAAAA (antisense exon 3) andlate transcripts in plasmid pMINX (Zillmann et al., 1988) by the se-
AATAATAATGGTGGTTATCC (sense exon 2) for Sxl RNAs; TCCAGGquence of Sxl intron 2 indicated in Figure 1A. Mutant derivatives
GTAGACCACCAG (antisense exon 2) and TGCACCTGACTCCTwere generated from this construct by PCR-based site-directed
GAGGA (sense exon 1) for -globin RNAs. PCR reactions were am-mutagenesis and confirmed by sequencing. pRmHA-TE234 and
plified for 25 cycles of 1 min at 94C, 1 min at 60C, and 30 s atpRmHA-SXL were described in Penalva et al. (2001). pRmHa- glo-
72C, followed by a final extension of 10 min at 72C. The productsbin and pRmHa-110 were generated by cloning a fragment of 
of amplification were analyzed by electrophoresis on nondenaturingglobin (or its -thalassemic variant 110) first intron and flanking
6% polyacrylamide gels.exons into the copper-inducible expression plasmid pRmHA.
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